David J. Moliterno, M.D. | Saha Cardiovascular Research Center

David J. Moliterno, M.D.

Connect
About
Publications

djmoli2@email.uky.edu
859-323-5025, 859-323-5843
329A C.T. Wethington Bldg, 900 S Limestone St, Lexington, KY 40536-0200
900 S. Limestone Street
Lexington, KY 40536-0200

Position(s):

Regular Faculty

Affiliation(s):

Internal Medicine

Cardiovascular Research Center

Other Affiliation(s):

CVRC - Affiliated Faculty

Internal Medicine - Cardiology

PubMed Publications:

Chandrasekhar, J.;Baber, U.;Sartori, S.;Aquino, M.;Tomey, M.;Kruckoff, M.;Moliterno, D.;Henry, T.D.;Weisz, G.;Gibson, C.M.;Iakovou, I.;Kini, A.;Faggioni, M.;Vogel, B.;Farhan, S.;Colombo, A.;Steg, P.G.;Witzenbichler, B.;Chieffo, A.;Cohen, D.;Stuckey, T.;Ariti, C.;Pocock, S.;Dangas, G.;Mehran, R. "Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry." International journal of cardiology 243, (2017): 132-139. [PubMed Link] | [ Full text ]
Schoos, M.;Chandrasekhar, J.;Baber, U.;Bhasin, A.;Sartori, S.;Aquino, M.;Vogel, B.;Farhan, S.;Sorrentino, S.;Kini, A.;Kruckoff, M.;Moliterno, D.;Henry, T.D.;Weisz, G.;Gibson, C.M.;Iakovou, I.;Colombo, A.;Steg, P.G.;Witzenbichler, B.;Chieffo, A.;Cohen, D.;Stuckey, T.;Ariti, C.;Dangas, G.;Pocock, S.;Mehran, R. "Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry)." The American journal of cardiology 120, 6 (2017): 904-910. [PubMed Link] | [ Full text ]
Shah, B.;Baber, U.;Pocock, S.J.;Krucoff, M.W.;Ariti, C.;Gibson, C.M.;Steg, P.G.;Weisz, G.;Witzenbichler, B.;Henry, T.D.;Kini, A.S.;Stuckey, T.;Cohen, D.J.;Iakovou, I.;Dangas, G.;Aquino, M.B.;Sartori, S.;Chieffo, A.;Moliterno, D.J.;Colombo, A.;Mehran, R. "White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry)." Circulation. Cardiovascular interventions 10, 9 (2017): [PubMed Link] |
Koshizaka, M.;Lopes, R.D.;Newby, L.K.;Clare, R.M.;Schulte, P.J.;Tricoci, P.;Mahaffey, K.W.;Ogawa, H.;Moliterno, D.J.;Giugliano, R.P.;Huber, K.;James, S.;Harrington, R.A.;Alexander, J.H. "Obesity, Diabetes, and Acute Coronary Syndrome: Differences Between Asians and Whites." The American journal of medicine 130, 10 (2017): 1170-1176. [PubMed Link] | [ Full text ]
Valgimigli, M.;Costa, F.;Lokhnygina, Y.;Clare, R.M.;Wallentin, L.;Moliterno, D.J.;Armstrong, P.W.;White, H.D.;Held, C.;Aylward, P.E.;Van de Werf, F.;Harrington, R.A.;Mahaffey, K.W.;Tricoci, P. "Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial." European heart journal 38, 11 (2017): 804-810. [PubMed Link] | [ Full text ]
Harskamp, R.E.;Clare, R.M.;Ambrosio, G.;Held, C.;Lokhnygina, Y.;Moliterno, D.J.;White, H.D.;Aylward, P.E.;Armstrong, P.W.;Mahaffey, K.W.;Harrington, R.A.;Van de Werf, F.;Wallentin, L.;Strony, J.;Tricoci, P. "Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial." European heart journal. Acute cardiovascular care 6, 2 (2017): 155-163. [PubMed Link] | [ Full text ]
Chandrasekhar, J.;Bansilal, S.;Baber, U.;Sartori, S.;Aquino, M.;Farhan, S.;Vogel, B.;Faggioni, M.;Giustino, G.;Ariti, C.;Colombo, A.;Chieffo, A.;Kini, A.;Saporito, R.;Michael Gibson, C.;Witzenbichler, B.;Cohen, D.;Moliterno, D.;Stuckey, T.;Henry, T.;Pocock, S.;Dangas, G.;Gabriel Steg, P.;Mehran, R. "Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry." Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 89, 7 (2017): E217-E225. [PubMed Link] | [ Full text ]
Moliterno, D.J.;Ziada, K.M. "More Time to SORT OUT Clinical Outcomes After First-Generation Drug-Eluting Stents: Related Versus Unrelated Events." Journal of the American College of Cardiology 69, 6 (2017): 625-627. [PubMed Link] | [ Full text ]
Faggioni, M.;Baber, U.;Sartori, S.;Giustino, G.;Cohen, D.J.;Henry, T.D.;Farhan, S.;Ariti, C.;Dangas, G.;Gibson, M.;Giacoppo, D.;Krucoff, M.W.;Aquino, M.;Chandrasekhar, J.;Moliterno, D.J.;Colombo, A.;Vogel, B.;Chieffo, A.;Kini, A.S.;Witzenbichler, B.;Weisz, G.;Steg, P.G.;Pocock, S.;Mehran, R. "Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry." JACC. Cardiovascular interventions 10, 7 (2017): 645-654. [PubMed Link] | [ Full text ]
Faggioni, M.;Chandrasekhar, J.;Baber, U.;Vogel, B.;Moliterno, D.;Henry, T.;Steg, P.G.;Colombo, A.;Gibson, C.;Pocock, S.;Witzenbichler, B.;Chieffo, A.;Cohen, D.;Weisz, G.;Kini, A.;Dangas, G.;Krucoff, M.;Mehran, R. "TCT-219 Influence Of Anemia On Physician-Recommended DAPT Discontinuation After Percutaneous Coronary Intervention." Journal of the American College of Cardiology 68, 18S (2016): B89. [PubMed Link] | [ Full text ]
Chandrasekhar, J.;Baber, U.;Sartori, S.;Pinnelas, R.;Henry, T.;Moliterno, D.;Cohen, D.;Weisz, G.;Kini, A.;Bruckel, J.;Pocock, S.;Steg, P.G.;Witzenbichler, B.;Colombo, A.;Chieffo, A.;Iakovou, I.;Dangas, G.;Gibson, C.M.;Stuckey, T.;Mehran, R. "TCT-211 Incidence and Impact of Dual Antiplatelet Therapy Cessation on Clinical Outcomes in Patients with Renal Dysfunction: Insights from the PARIS Registry." Journal of the American College of Cardiology 68, 18S (2016): B86. [PubMed Link] | [ Full text ]
Leisman, D.;Baber, U.;Cohen, D.;Gibson, C.M.;Pocock, S.;Henry, T.;Steg, P.G.;Dangas, G.;Moliterno, D.;Witzenbichler, B.;Kini, A.;Krucoff, M.;Bruckel, J.;Colombo, A.;Chieffo, A.;Mehran, R. "TCT-206 Tailoring the Intensity of Antiplatelet Pharmacotherapy to Ischemic and Bleeding Risk: A Cost Optimizing Simulation From PARIS." Journal of the American College of Cardiology 68, 18S (2016): B84. [PubMed Link] | [ Full text ]
Chandrasekhar, J.;Baber, U.;Sartori, S.;Aquino, M.;Stuckey, T.;Henry, T.;Moliterno, D.;Cohen, D.;Steg, P.G.;Iakovou, I.;Bruckel, J.;Pocock, S.;Kini, A.;Colombo, A.;Chieffo, A.;Witzenbichler, B.;Weisz, G.;Dangas, G.;Gibson, C.M.;Mehran, R. "TCT-205 Incidence and clinical outcomes associated with DAPT discontinuation in complex PCI patients: From the PARIS registry." Journal of the American College of Cardiology 68, 18S (2016): B83-B84. [PubMed Link] | [ Full text ]
Angiolillo, D.J.;Goodman, S.G.;Bhatt, D.L.;Eikelboom, J.W.;Price, M.J.;Moliterno, D.J.;Cannon, C.P.;Tanguay, J.F.;Granger, C.B.;Mauri, L.;Holmes, D.R.;Gibson, C.M.;Faxon, D.P. "Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update." Circulation. Cardiovascular interventions 9, 11 (2016): [PubMed Link] | [ Full text ]
Baber, U.;Mehran, R.;Giustino, G.;Cohen, D.J.;Henry, T.D.;Sartori, S.;Ariti, C.;Litherland, C.;Dangas, G.;Gibson, C.M.;Krucoff, M.W.;Moliterno, D.J.;Kirtane, A.J.;Stone, G.W.;Colombo, A.;Chieffo, A.;Kini, A.S.;Witzenbichler, B.;Weisz, G.;Steg, P.G.;Pocock, S. "Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS." Journal of the American College of Cardiology 67, 19 (2016): 2224-34. [PubMed Link] | [ Full text ]
Vranckx, P.;White, H.D.;Huang, Z.;Mahaffey, K.W.;Armstrong, P.W.;Van de Werf, F.;Moliterno, D.J.;Wallentin, L.;Held, C.;Aylward, P.E.;Cornel, J.H.;Bode, C.;Huber, K.;Nicolau, J.C.;Ruzyllo, W.;Harrington, R.A.;Tricoci, P. "Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial." Journal of the American College of Cardiology 67, 18 (2016): 2135-44. [PubMed Link] | [ Full text ]
Popma, C.J.;Sheng, S.;Korjian, S.;Daaboul, Y.;Chi, G.;Tricoci, P.;Huang, Z.;Moliterno, D.J.;White, H.D.;Van de Werf, F.;Harrington, R.A.;Wallentin, L.;Held, C.;Armstrong, P.W.;Aylward, P.E.;Strony, J.;Mahaffey, K.W.;Gibson, C.M. "Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy." Circulation. Cardiovascular interventions 9, 5 (2016): e003114. [PubMed Link] | [ Full text ]
Ziada, K.M.;Abdel-Latif, A.K.;Charnigo, R.;Moliterno, D.J. "Safety of an abbreviated duration of dual antiplatelet therapy (≤6 months) following second-generation drug-eluting stents for coronary artery disease: A systematic review and meta-analysis of randomized trials." Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 87, 4 (2016): 722-732. [PubMed Link] | [ Full text ]
Yu, J.;Baber, U.;Mastoris, I.;Dangas, G.;Sartori, S.;Steg, P.G.;Cohen, D.J.;Giustino, G.;Chandrasekhar, J.;Ariti, C.;Witzenbichler, B.;Henry, T.D.;Kini, A.S.;Krucoff, M.W.;Gibson, C.M.;Chieffo, A.;Moliterno, D.J.;Colombo, A.;Pocock, S.;Mehran, R. "Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents." JACC. Cardiovascular interventions 9, 14 (2016): 1461-9. [PubMed Link] | [ Full text ]
Baber, U.;Dangas, G.;Chandrasekhar, J.;Sartori, S.;Steg, P.G.;Cohen, D.J.;Giustino, G.;Ariti, C.;Witzenbichler, B.;Henry, T.D.;Kini, A.S.;Krucoff, M.W.;Gibson, C.M.;Chieffo, A.;Moliterno, D.J.;Weisz, G.;Colombo, A.;Pocock, S.;Mehran, R. "Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry." JACC. Cardiovascular interventions 9, 13 (2016): 1349-57. [PubMed Link] | [ Full text ]
Armaganijan, L.V.;Alexander, K.P.;Huang, Z.;Tricoci, P.;Held, C.;Van de Werf, F.;Armstrong, P.W.;Aylward, P.E.;White, H.D.;Moliterno, D.J.;Wallentin, L.;Chen, E.;Harrington, R.A.;Strony, J.;Mahaffey, K.W.;Lopes, R.D. "Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial." American heart journal 178, (2016): 176-84. [PubMed Link] | [ Full text ]
Åkerblom, A.;Clare, R.M.;Lokhnygina, Y.;Wallentin, L.;Held, C.;Van de Werf, F.;Moliterno, D.J.;Patel, U.D.;Leonardi, S.;Armstrong, P.W.;Harrington, R.A.;White, H.D.;Aylward, P.E.;Mahaffey, K.W.;Tricoci, P. "Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial." American heart journal 178, (2016): 1-8. [PubMed Link] | [ Full text ]
Déry, J.P.;Mahaffey, K.W.;Tricoci, P.;White, H.D.;Podder, M.;Westerhout, C.M.;Moliterno, D.J.;Harrington, R.A.;Chen, E.;Strony, J.;Van de Werf, F.;Ziada, K.M.;Held, C.;Aylward, P.E.;Armstrong, P.W.;Rao, S.V. "Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar." Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 88, 2 (2016): 163-73. [PubMed Link] | [ Full text ]
Hess, P.L.;Wojdyla, D.M.;Al-Khatib, S.M.;Lokhnygina, Y.;Wallentin, L.;Armstrong, P.W.;Roe, M.T.;Ohman, E.M.;Harrington, R.A.;Alexander, J.H.;White, H.D.;Van de Werf, F.;Piccini, J.P.;Held, C.;Aylward, P.E.;Moliterno, D.J.;Mahaffey, K.W.;Tricoci, P. "Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome." JAMA cardiology 1, 1 (2016): 73-9. [PubMed Link] | [ Full text ]